AMRUTANJAN HEALTH CARE
|
The Current P/E Ratio of AMRUTANJAN HEALTH CARE is 41.62.
Share Price | ₹684.4 | Jan 13,2025 |
Market Cap | ₹1,977.9 Cr | |
Earnings-TTM | ₹47.5 Cr | TTM-Standalone Results |
Price/Earnings | 41.62x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of AMRUTANJAN HEALTH CARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,977.9 Cr] as on Jan 13,2025
(/) Earnings [ ₹47.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 41.62x ]
Thus, for AMRUTANJAN HEALTH CARE , the investors are currently willing to pay 41.62 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AMRUTANJAN HEALTH CARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AMRUTANJAN HEALTH CARE over the last five years.
Historical PE (Price/Earnings) ratio chart of AMRUTANJAN HEALTH CARE
PE Ratio Performance Analysis for AMRUTANJAN HEALTH CARE
- AMRUTANJAN HEALTH CARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 36.42x.
- AMRUTANJAN HEALTH CARE 's operated at median p/e ratio of 38.45x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AMRUTANJAN HEALTH CARE 's p/e ratio peaked in Mar2023 at 42.19x.
- AMRUTANJAN HEALTH CARE 's p/e ratio hit its five-year low in Mar2021 of 27.15x.
How does AMRUTANJAN HEALTH CARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
AMRUTANJAN HEALTH CARE | 47.52 | 41.62 | 1,977.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 37.62 | 418,936.0 |
CIPLA LTD | 4,485.22 | 25.91 | 116,200.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.59 | 111,325.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.81 | 98,037.4 |
DIVIS LABORATORIES LTD | 1,836.00 | 82.87 | 152,157.0 |
MANKIND PHARMA LTD | 2,124.86 | 50.30 | 106,880.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 60.83 | 109,617.0 |
LUPIN LTD | 2,651.94 | 37.06 | 98,275.2 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.75 | 67,480.4 |
ABBOTT INDIA LTD | 1,284.66 | 47.22 | 60,664.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AMRUTANJAN HEALTH CARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.75x |
Max industry PE | 82.87x |
Median industry PE | 37.62x |
Average industry PE | 40.51x |
You may also like the below Video Courses